Skip to main content
Caplight Logo









ZOMP

ZOMP

Private
CambridgeHealthcare & Life Scienceshttps://www.zomp.one/

Last Round

Seed

May 30, 2023

Total Funding Raised

$4.98M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ZOMP is a life sciences company developing a 3D imaging flow cytometer to analyze and sort cells for applications in immunotherapy, drug discovery, and cancer diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Imaging, Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

flow cytometry3D imagingcellular imagingbiotech equipmentcomputational imagingcell sortingmedical imagingdrug discoveryimmunotherapyoncology researchlab automationhigh-content screeningsingle-cell analysismicrofluidicsphenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZOMP Comparables

Compare ZOMP with similar companies based on industry and business-model similarity.

ZOMP comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deepcell
78%
ThinkCyte
77%
NanoCellect Biomedical
75%

ZOMP Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 30, 2023
SeedApr 17, 2023

Key People

Founding team and executive leadership

Kevin Serradas O'Holleran

Co-Founder, CEO CTO

Founding Team

ZOMP Investors

Notable investors and investment history

ZOMP investors
InvestorRounds
BGFSeed
Cambridge EnterpriseSeed
Foresight Williams TechnologySeed
ZEISS VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Open roles increased to 3, 3x the trailing average.

  • Aug 3, 2026

    Open roles increased to 2, 3x the trailing average.

ZOMP Filings

Explore SEC and related filing metadata, where available.

ZOMP filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZOMP's valuation, stock price, and market status.

Is ZOMP a public or private company?

ZOMP is a private company.

What is the current stock price of ZOMP?

ZOMP is a private company with no public stock price. No recent secondary market data is available.

How much is ZOMP worth (valuation)?

Valuation information for ZOMP is not publicly available.

Can I buy ZOMP stock?

ZOMP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZOMP's last funding round?

ZOMP's most recent funding round was Seed on May 30, 2023.

Who are the main investors in ZOMP?

Key investors in ZOMP include BGF, Foresight Williams Technology, ZEISS Ventures.

Will ZOMP IPO soon?

No public IPO plans have been announced for ZOMP.

How can I track ZOMP secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZOMP's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range8
Year Founded2021
Last FundingMay 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?